According to ARS, the FDA regulators decided at the time that more data was needed to evaluate the safety of repeated doses of the nasal spray before it could be approved. "Neffy is epinephrine ...

On Friday, the FDA announced the approval of neffy, an epinephrine nasal spray by ARS Pharmaceuticals ... associate director of the Division of Pulmonology, Allergy and Critical Care in the ...

On 9 August, US health officials approved the first nasal spray to treat allergic ... of the Division of Pulmonology, Allergy and Critical Care in the FDA’s Center for Drug Evaluation and ...

March 6, 2025 – The FDA has approved a new nose spray that can quickly treat severe ... Common side effects include nasal discomfort or tingling, nosebleeds, sneezing, runny or dry nose or ...

ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first ... associate director of the division of pulmonology, allergy and critical care at the FDA's Center ...

Neffy, as the product is called, is a nasal spray that delivers the same drug used to treat anaphylaxis. It is ARS’ flagship product. Friday’s approval comes after the FDA stalled neffy’s ...

The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis ... to a needle-free option for the treatment of severe allergies and reduce hesitation in treating this vulnerable ...

Emergency crews were called to the scene after a semi crashed into a building in West Chicago on Wednesday afternoon. A federal judge is expected to rule on a request to stop President Trump's ...